Clinical Trial

Efficacy of Multimodal Analgesia Following Hip Arthroscopy

Study Description

Efficacy of Multimodal Analgesia Following Hip Arthroscopy

The purpose of the full study is to determine whether multimodal analgesia for hip arthroscopy will reduce post-operative pain scores, narcotic consumption and hospital length-of-stay. To do this, the investigators will compare the standard of care (SOC), with routine pain management with a post-operative opioid prescription, to three different groups with multi-modal analgesia (SOC+peri-operative celecoxib, SOC+peri-operative gabapentin, and SOC+post-operative zopiclone). The investigators hypothesize that administration of multi-modal analgesia in all three treatment groups will result in improved post-operative pain control, reduced post-operative narcotic consumption and an overall reduction in post-operative length-of-stay compared to the group receiving treatment as per the standard of care. However, prior to undertaking a large multi-centre study, the investigators need to determine whether the study is feasible from data obtained with this pilot study.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Drug - Naprosyn

Standard of Care

Drug - Percocet

Standard of Care

Drug - Zopiclone

Group 2 - Zopiclone 7.5 mg orally, nightly for 7 days

Drug - Gabapentin

Group 3 - Gabapentin 600 mg orally, 1 hour pre-operatively and 600 mg orally, 8 hours post-operatively

Drug - Celebrex

Group 4 - Celebrex 400 mg PO, 1 hour pre-operatively

Additional Information

Official Study Title

Efficacy of Multimodal Analgesia Following Hip Arthroscopy

Clinical Trial ID

NCT03351439

ParticipAid ID

PdRx0a